1 / 13

Open Public Hearing

Open Public Hearing. Congresswoman Donna M. Christensen, M.D. Chair, Congressional Black Caucus [CBC]. Cardiovascular and Renal Drugs Advisory Committee June 16, 2005. Open Public Hearing. Gary A. Puckrein, Ph.D. National Minority Health Month Foundation.

Télécharger la présentation

Open Public Hearing

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Open Public Hearing • Congresswoman Donna M. Christensen, M.D. Chair, Congressional Black Caucus [CBC] Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

  2. Open Public Hearing • Gary A. Puckrein, Ph.D. National Minority Health Month Foundation Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

  3. Open Public Hearing 3. B. Waine Kong, J.D., Ph.D. CEO – American Association of Black Cardiologists [ABC] Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

  4. Open Public Hearing • Debra Lee Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

  5. Open Public Hearing 5. Shomarka Omar Y. Keita, M.D., D.Phil. Medical Officer -Department of Human Services, District of Columbia Research Associate - Anthropology Department, Smithsonian Institution * Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

  6. Open Public Hearing • Jonathan Kahn, J.D., Ph.D. Assistant Professor Hamline University School of Law Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

  7. Open Public Hearing 7. Charles L. Curry, M.D., FACC, FACP President - International Society on Hypertension in Blacks Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

  8. Open Public Hearing 8. Basil Halliday, M.Sc. President & CEO - BDH Clinical Research Services * Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

  9. Open Public Hearing • Charles N. Rotimi, Ph.D. National Human Genome Center Howard University * Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

  10. Open Public Hearing • Charmaine Royal, Ph.D. National Human Genome Center Howard University * Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

  11. Open Public Hearing • Olivia Carter-Pokras, Ph.D. Associate Professor – University of Maryland, School of Medicine, Dept. of Epidemiology Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

  12. Open Public Hearing • Lucille C. Norville Perez, MD National Health Director - National Association for the Advancement of Colored People Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

  13. Open Public Hearing 13. Dianna Wells Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

More Related